Mary J Ninan, Yvonne H Datta. Show Affiliations »
Abstract
Entities: Disease
Mesh： See more » Antibodies, Monoclonal/therapeutic useAntibodies, Monoclonal, Murine-DerivedAntineoplastic Combined Chemotherapy Protocols/therapeutic useCyclophosphamide/administration & dosageDiabetic Nephropathies/surgeryDisease ProgressionEpstein-Barr Virus Infections/drug therapyEpstein-Barr Virus Infections/etiologyEpstein-Barr Virus Infections/virologyFatal OutcomeGanciclovir/therapeutic useHumansImmunosuppressive Agents/adverse effectsKidney TransplantationLumbar VertebraeLymphoproliferative Disorders/drug therapyLymphoproliferative Disorders/etiologyLymphoproliferative Disorders/virologyMaleMiddle AgedMultiple Myeloma/drug therapyMultiple Myeloma/etiologyMultiple Myeloma/virologyMycophenolic Acid/administration & dosageMycophenolic Acid/adverse effectsMycophenolic Acid/analogs & derivativesPancreas TransplantationPlasmacytoma/drug therapyPlasmacytoma/radiotherapyPostoperative Complications/etiologyPostoperative Complications/virologyPrednisone/administration & dosagePrednisone/adverse effectsReoperationRituximabSpinal Neoplasms/drug therapySpinal Neoplasms/radiotherapyTacrolimus/administration & dosageTacrolimus/adverse effectsThalidomide/administration & dosage
Substances： See more » Antibodies, MonoclonalAntibodies, Monoclonal, Murine-DerivedImmunosuppressive AgentsRituximabThalidomideCyclophosphamideMycophenolic AcidGanciclovirPrednisoneTacrolimus
Year: 2010 PMID： 20578201 DOI： 10.1002/ajh.21762
Source DB: PubMed Journal: Am J Hematol ISSN： 0361-8609 Impact factor: 10.047